Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.

Yaspan BL, Williams DF, Holz FG, Regillo CD, Li Z, Dressen A, van Lookeren Campagne M, Le KN, Graham RR, Beres T, Bhangale TR, Honigberg LA, Smith A, Henry EC, Ho C, Strauss EC; MAHALO Study Investigators.

Sci Transl Med. 2017 Jun 21;9(395). pii: eaaf1443. doi: 10.1126/scitranslmed.aaf1443.

PMID:
28637922
2.

Age-related macular degeneration: Complement in action.

van Lookeren Campagne M, Strauss EC, Yaspan BL.

Immunobiology. 2016 Jun;221(6):733-9. doi: 10.1016/j.imbio.2015.11.007. Epub 2015 Dec 19. Review.

3.

Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy.

Le KN, Gibiansky L, van Lookeren Campagne M, Good J, Davancaze T, Loyet KM, Morimoto A, Strauss EC, Jin JY.

CPT Pharmacometrics Syst Pharmacol. 2015 Oct;4(10):595-604. doi: 10.1002/psp4.12031. Epub 2015 Oct 8.

4.

Geographic atrophy: clinical features and potential therapeutic approaches.

Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M.

Ophthalmology. 2014 May;121(5):1079-91. doi: 10.1016/j.ophtha.2013.11.023. Epub 2014 Jan 14. Review.

PMID:
24433969
5.

A phase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy.

Do DV, Pieramici DJ, van Lookeren Campagne M, Beres T, Friesenhahn M, Zhang Y, Strauss EC; Phase Ia Investigators.

Retina. 2014 Feb;34(2):313-20. doi: 10.1097/IAE.0b013e3182979ddd.

PMID:
23842100
6.

Vascular endothelial growth factor a in intraocular vascular disease.

Miller JW, Le Couter J, Strauss EC, Ferrara N.

Ophthalmology. 2013 Jan;120(1):106-14. doi: 10.1016/j.ophtha.2012.07.038. Epub 2012 Sep 29. Review.

PMID:
23031671
7.

Membrane array analysis of tear proteins in ocular cicatricial pemphigoid.

Chan MF, Sack R, Quigley DA, Sathe S, Vijmasi T, Li S, Holsclaw D, Strauss EC, McNamara NA.

Optom Vis Sci. 2011 Aug;88(8):1005-9. doi: 10.1097/OPX.0b013e31821ddc6c.

8.

Perifosine-related rapidly progressive corneal ring infiltrate.

Keenan JD, Fram NR, McLeod SD, Strauss EC, Margolis TP.

Cornea. 2010 May;29(5):583-5. doi: 10.1097/ICO.0b013e3181b55cd8.

PMID:
20335808
9.

An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.

DeVoss JJ, LeClair NP, Hou Y, Grewal NK, Johannes KP, Lu W, Yang T, Meagher C, Fong L, Strauss EC, Anderson MS.

J Immunol. 2010 Apr 15;184(8):4236-46. doi: 10.4049/jimmunol.0902434. Epub 2010 Mar 17.

10.

Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus.

Hu AY, Strauss EC, Holland GN, Chan MF, Yu F, Margolis TP.

Am J Ophthalmol. 2010 Feb;149(2):214-220.e3. doi: 10.1016/j.ajo.2009.08.030. Epub 2009 Nov 11.

11.

Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1.

Devoss JJ, Shum AK, Johannes KP, Lu W, Krawisz AK, Wang P, Yang T, Leclair NP, Austin C, Strauss EC, Anderson MS.

J Immunol. 2008 Sep 15;181(6):4072-9.

12.

Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.

Li S, Nikulina K, DeVoss J, Wu AJ, Strauss EC, Anderson MS, McNamara NA.

Invest Ophthalmol Vis Sci. 2008 Jan;49(1):34-41. doi: 10.1167/iovs.07-0685.

13.

"Steel wool keratopathy": a clinical sign of chronic inflammation.

Seitzman GD, Strauss EC, Margolis TP.

Cornea. 2006 Jul;25(6):742-4.

PMID:
17077672
14.

Metaplastic squamous epithelial downgrowth after clear corneal cataract surgery.

Stone DU, Char DH, Crawford JB, Margolis TP, Van Gelder RN, Strauss EC.

Am J Ophthalmol. 2006 Oct;142(4):695-7.

PMID:
17011874
15.

Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco.

Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG.

Arch Ophthalmol. 2006 Jul;124(7):1051-3. Epub 2006 Jun 12. No abstract available.

PMID:
16769826
16.

Management of prominent iris vascular tufts causing recurrent spontaneous hyphema.

Strauss EC, Aldave AJ, Spencer WH, Branco BC, Barsness DA, Calman AF, Margolis TP.

Cornea. 2005 Mar;24(2):224-6.

PMID:
15725893
17.

Diagnosis of conjunctival B-cell lymphoma by polymerase chain reaction heteroduplex analysis.

Strauss EC, Warren JF, Margolis TP, Holsclaw DS.

Am J Ophthalmol. 2003 Jul;136(1):207-9.

PMID:
12834702
18.

Atopic ocular disease.

Strauss EC, Foster CS.

Ophthalmol Clin North Am. 2002 Mar;15(1):1-5. Review.

PMID:
12064072
19.

Guanine-adenine ligation-mediated polymerase chain reaction in vivo footprinting.

Strauss EC, Orkin SH.

Methods Enzymol. 1999;304:572-84.

PMID:
10372382
20.

Soluble P-selectin glycoprotein ligand 1 inhibits ocular inflammation in a murine model of allergy.

Strauss EC, Larson KA, Brenneise I, Foster CS, Larsen GR, Lee NA, Lee JJ.

Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1336-42.

PMID:
10359314
21.

Guanine-adenine ligation-mediated PCR in vivo footprinting.

Strauss EC, Orkin SH.

Methods. 1997 Feb;11(2):164-70.

PMID:
8993028
22.
24.

CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.

Skalnik DG, Strauss EC, Orkin SH.

J Biol Chem. 1991 Sep 5;266(25):16736-44.

25.

Analysis of a human V beta gene subfamily.

Siu G, Strauss EC, Lai E, Hood LE.

J Exp Med. 1986 Nov 1;164(5):1600-14.

26.

Specific-primer-directed DNA sequencing.

Strauss EC, Kobori JA, Siu G, Hood LE.

Anal Biochem. 1986 Apr;154(1):353-60.

PMID:
3010776

Supplemental Content

Loading ...
Support Center